This will be Aster’s fifth hospital in Bengaluru
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
EBITDA rose to Rs. 218.1 crore, a 14.8% year-on-year increase
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Subscribe To Our Newsletter & Stay Updated